CEFTAZIDIME, AVIBACTAM

CEFTAZIDIME, AVIBACTAM was reported 169 times

These side effects are most commonly reported by patients taking CEFTAZIDIME, AVIBACTAM:

# Side effect Count
0 OFF LABEL USE 34
1 PRODUCT STORAGE ERROR 15
2 DRUG RESISTANCE 12
3 RESPIRATORY FAILURE 9
4 ACUTE KIDNEY INJURY 8
5 HYPOTENSION 7
6 MENTAL STATUS CHANGES 7
7 PYREXIA 7
8 DEATH 6
9 DYSPNOEA 6
10 HEADACHE 6
11 NAUSEA 6
12 DRUG INEFFECTIVE 5
13 PNEUMONIA 5
14 ABDOMINAL PAIN 4
15 ENCEPHALOPATHY 4
16 FATIGUE 4
17 PAIN 4
18 PRODUCT STORAGE ISSUE 4
19 SEIZURE 4
20 SEPTIC SHOCK 4
21 CHEST DISCOMFORT 3
22 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3
23 CONFUSIONAL STATE 3
24 DIARRHOEA 3
25 DIZZINESS 3
26 HEPATIC ENZYME INCREASED 3
27 INCORRECT DRUG ADMINISTRATION RATE 3
28 MALAISE 3
29 PATHOGEN RESISTANCE 3
30 PRODUCT NAME CONFUSION 3
31 THERAPY CESSATION 3
32 VOMITING 3
33 ASPERGILLUS INFECTION 2
34 CONSTIPATION 2
35 COUGH 2
36 COVID-19 2
37 COVID-19 PNEUMONIA 2
38 CYSTIC FIBROSIS 2
39 DELIRIUM 2
40 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2
41 EXTRAVASATION 2
42 GASTROINTESTINAL HAEMORRHAGE 2
43 GENERAL PHYSICAL HEALTH DETERIORATION 2
44 HAEMOLYTIC ANAEMIA 2
45 HYSTERECTOMY 2
46 INCORRECT DOSE ADMINISTERED 2
47 INCORRECT PRODUCT ADMINISTRATION DURATION 2
48 INTENTIONAL PRODUCT MISUSE 2
49 INTERCEPTED PRODUCT SELECTION ERROR 2
50 JOINT SWELLING 2
51 KLEBSIELLA TEST POSITIVE 2
52 LIVER FUNCTION TEST INCREASED 2
53 LUNG INFILTRATION 2
54 MULTIPLE-DRUG RESISTANCE 2
55 MUSCULAR WEAKNESS 2
56 MYOCLONUS 2
57 NEOPLASM MALIGNANT 2
58 NO ADVERSE EVENT 2
59 OEDEMA PERIPHERAL 2
60 OVERDOSE 2
61 PERIPHERAL SWELLING 2
62 PNEUMONIA PSEUDOMONAL 2
63 PRODUCT ADMINISTRATION ERROR 2
64 PRODUCT DISPENSING ERROR 2
65 PRURITUS 2
66 RADICAL CYSTECTOMY 2
67 RASH ERYTHEMATOUS 2
68 RASH PRURITIC 2
69 RECTAL HAEMORRHAGE 2
70 RENAL INJURY 2
71 SEPSIS 2
72 SOFT TISSUE NECROSIS 2
73 STEVENS-JOHNSON SYNDROME 2
74 THROMBOCYTOPENIA 2
75 TOXIC EPIDERMAL NECROLYSIS 2
76 URINARY TRACT INFECTION 2
77 WEIGHT INCREASED 2
78 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
79 ACUTE PROMYELOCYTIC LEUKAEMIA 1
80 AGITATION 1
81 ANAPHYLACTIC REACTION 1
82 ANORECTAL INFECTION 1
83 ANTIMICROBIAL SUSCEPTIBILITY TEST 1
84 AORTIC ARTERIOSCLEROSIS 1
85 APHASIA 1
86 ARTERIOSCLEROSIS CORONARY ARTERY 1
87 ARTHRALGIA 1
88 ARTHRITIS INFECTIVE 1
89 ASPIRATION JOINT 1
90 ATELECTASIS 1
91 ATRIAL ENLARGEMENT 1
92 ATRIAL FIBRILLATION 1
93 BACTERAEMIA 1
94 BLOOD ALKALINE PHOSPHATASE INCREASED 1
95 BLOOD BILIRUBIN INCREASED 1
96 BLOOD CREATININE INCREASED 1
97 BLOOD PRESSURE INCREASED 1
98 BLOOD URINE PRESENT 1
99 BRONCHIECTASIS 1
100 BURKHOLDERIA TEST POSITIVE 1
101 C-REACTIVE PROTEIN INCREASED 1
102 CANDIDA INFECTION 1
103 CARDIAC ARREST 1
104 CARDIO-RESPIRATORY ARREST 1
105 CATARACT 1
106 CATHETER SITE ERYTHEMA 1
107 CATHETER SITE PRURITUS 1
108 CELLULITIS 1
109 CENTRAL VENOUS CATHETERISATION 1
110 CHEST PAIN 1
111 CHILLS 1
112 CHOLESTASIS 1
113 CHROMATURIA 1
114 CLOSTRIDIUM DIFFICILE COLITIS 1
115 CONTRAINDICATED PRODUCT ADMINISTERED 1
116 CYTOMEGALOVIRUS VIRAEMIA 1
117 DECREASED APPETITE 1
118 DERMATITIS ALLERGIC 1
119 DISEASE RISK FACTOR 1
120 DRUG DISPENSING ERROR 1
121 DRUG DOSE TITRATION NOT PERFORMED 1
122 DRUG-INDUCED LIVER INJURY 1
123 DRY EYE 1
124 DRY MOUTH 1
125 DRY SKIN 1
126 DYSKINESIA 1
127 DYSPHAGIA 1
128 DYSURIA 1
129 EAR CONGESTION 1
130 ELECTROCARDIOGRAM QT PROLONGED 1
131 ERUCTATION 1
132 ERYTHEMA 1
133 EXERCISE TOLERANCE DECREASED 1
134 FALL 1
135 FEBRILE NEUTROPENIA 1
136 FORCED EXPIRATORY VOLUME DECREASED 1
137 FRACTURE 1
138 FUNGAL INFECTION 1
139 GAIT DISTURBANCE 1
140 GENERALISED OEDEMA 1
141 GINGIVAL DISCOLOURATION 1
142 GLAUCOMA 1
143 GLOMERULAR FILTRATION RATE INCREASED 1
144 GLUCOSE URINE PRESENT 1
145 HAEMOGLOBIN DECREASED 1
146 HAEMOPTYSIS 1
147 HAEMORRHAGE 1
148 HAND DEFORMITY 1
149 HEART RATE INCREASED 1
150 HEPATIC CANCER 1
151 HEPATIC CIRRHOSIS 1
152 HEPATITIS 1
153 HIP ARTHROPLASTY 1
154 HOSPITALISATION 1
155 HYPERGLYCAEMIA 1
156 HYPERKALAEMIA 1
157 HYPERSENSITIVITY 1
158 HYPERTENSION 1
159 HYPOACUSIS 1
160 HYPOGLYCAEMIA 1
161 HYPONATRAEMIA 1
162 HYPOXIA 1
163 ILLNESS 1
164 INCORRECT PRODUCT FORMULATION ADMINISTERED 1
165 INFECTION 1
166 INFLUENZA LIKE ILLNESS 1
167 INFUSION SITE EXTRAVASATION 1
168 INFUSION SITE SWELLING 1
169 INJECTION SITE EXTRAVASATION 1
170 INSOMNIA 1
171 INTENTIONAL PRODUCT USE ISSUE 1
172 INTERCEPTED PRODUCT DISPENSING ERROR 1
173 INTERNATIONAL NORMALISED RATIO INCREASED 1
174 INTERVERTEBRAL DISC DISORDER 1
175 INTUSSUSCEPTION 1
176 ISCHAEMIA 1
177 JAUNDICE 1
178 KLEBSIELLA INFECTION 1
179 LACTIC ACIDOSIS 1
180 LACUNAR INFARCTION 1
181 LEUKOCYTOSIS 1
182 LIMB DISCOMFORT 1
183 LIVER FUNCTION TEST ABNORMAL 1
184 LUNG NEOPLASM MALIGNANT 1
185 MELAENA 1
186 MENTAL DISORDER 1
187 MOUTH ULCERATION 1
188 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
189 MULTIPLE SCLEROSIS 1
190 MULTIPLE USE OF SINGLE-USE PRODUCT 1
191 MYELODYSPLASTIC SYNDROME 1
192 NASAL INFLAMMATION 1
193 NEUROPATHY PERIPHERAL 1
194 NEUTROPENIA 1
195 NOCTURIA 1
196 NON-CARDIAC CHEST PAIN 1
197 OCCUPATIONAL EXPOSURE TO PRODUCT 1
198 OEDEMA 1
199 PALLOR 1
200 PANCYTOPENIA 1
201 PLEURAL EFFUSION 1
202 PNEUMONIA ASPIRATION 1
203 POLYURIA 1
204 POOR QUALITY PRODUCT ADMINISTERED 1
205 POST PROCEDURAL INFLAMMATION 1
206 PREGNANCY 1
207 PROCEDURAL PNEUMOTHORAX 1
208 PRODUCT AVAILABILITY ISSUE 1
209 PRODUCT CONTAINER ISSUE 1
210 PRODUCT CONTAMINATION MICROBIAL 1
211 PRODUCT CONTAMINATION PHYSICAL 1
212 PRODUCT DISPENSING ISSUE 1
213 PRODUCT DISTRIBUTION ISSUE 1
214 PRODUCT DOSE OMISSION ISSUE 1
215 PRODUCT LABEL ISSUE 1
216 PRODUCT PREPARATION ERROR 1
217 PRODUCT PREPARATION ISSUE 1
218 PRODUCT PRESCRIBING ISSUE 1
219 PRODUCT QUALITY ISSUE 1
220 PRODUCT USE IN UNAPPROVED INDICATION 1
221 QRS AXIS ABNORMAL 1
222 RASH 1
223 RASH GENERALISED 1
224 RENAL FAILURE 1
225 RESPIRATORY DISTRESS 1
226 SCLEROTHERAPY 1
227 SECRETION DISCHARGE 1
228 SHOCK HAEMORRHAGIC 1
229 SINUS CONGESTION 1
230 SINUS TACHYCARDIA 1
231 SINUSITIS 1
232 SJOGREN^S SYNDROME 1
233 SKIN BURNING SENSATION 1
234 SKIN DISCOLOURATION 1
235 SKIN HYPERPIGMENTATION 1
236 SKIN WEEPING 1
237 SOMNOLENCE 1
238 SPINAL OPERATION 1
239 STATUS EPILEPTICUS 1
240 SWELLING 1
241 THERAPEUTIC EMBOLISATION 1
242 THERAPEUTIC RESPONSE UNEXPECTED 1
243 THERAPY INTERRUPTED 1
244 THROMBOSIS 1
245 TINNITUS 1
246 TONGUE DISCOMFORT 1
247 TOOTH DISCOLOURATION 1
248 TRANSAMINASES INCREASED 1
249 TREATMENT NONCOMPLIANCE 1
250 VISUAL IMPAIRMENT 1
251 WEIGHT DECREASED 1
252 WHITE BLOOD CELL COUNT DECREASED 1
253 WHITE BLOOD CELL COUNT INCREASED 1